Taking ALPS down a notch

Blood

Volumn 111, Issue 2, 2008, Pages 477-

  Rao, V Koneti ^a  

^a National Institutes of Health

Author keywords

[No Author keywords available]

Indexed keywords

NOTCH RECEPTOR;

ANTIBODY PRODUCTION; APOPTOSIS; AUTOIMMUNE DISEASE; AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; B CELL LYMPHOMA; CYTOPENIA; DISEASE SEVERITY; GENE MUTATION; HEPATOSPLENOMEGALY; HUMAN; LYMPHADENOPATHY; LYMPHOCYTE PROLIFERATION; LYMPHOPROLIFERATIVE DISEASE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SHORT SURVEY; T LYMPHOCYTE;

EID: 38349172125     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2007-10-119479     Document Type: Short Survey

References (6)

1. Tanigaki K, Honjo T. Regulation of lymphocyte development by Notch signaling. Nat Immunol. 2007;8:451-456.
2. Sneller MC, Straus SE, Jaffe ES, et al. A novel lymphoproliferative/ autoimmune syndrome resembling murine lpr/gld disease. J Clin Invest. 1992;90:334-341.
3. Rao VK, Straus SE. Causes and consequences of the autoimmune lymphoproliferative syndrome. Hematology. 2006;11:15-23.
4. Pissarnitski D. Advances in gamma-secretase modulation. Curr Opin Drug Discov Devel. 2007;10:392-402.
5. MacDermott EJ, Adams A, Lehman T. Review: Systemic lupus erythematosus in children: current and emerging therapies. Lupus. 2007;16:677-683.
6. Stockhausen MT, Sjolund J, Manetopoulos C, Axelson H. Effects of the histone deacetylase inhibitor valproic acid on Notch signalling in human neuroblastoma cells. Br J Cancer. 2005;92:751-759.